Access cutting-edge greater trochanteric pain syndrome treatment through this clinical trial at a research site in The Bronx. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this The Bronx location
Preparing your pre-screening questions…
Access greater trochanteric pain syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related greater trochanteric pain syndrome treatment provided free
Check if you qualify for this greater trochanteric pain syndrome clinical trial in The Bronx, NY
No-Cost Study Care
Local to The Bronx
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The objective of this study is to evaluate how an ultrasound-guided percutaneous procedure, TENEX, can help people with chronic hip pain resulting from a condition called Greater Trochanteric Pain Syndrome (GTPS) and to characterize the efficacy of percutaneous tenotomy (PUT) using TENEX®, a device used for the treatment of various tendinopathies. In this study an ultrasound (US) is performed to guide the partial release of gluteus medius and minimus and Iliotibial band tendons in patients diagnosed with refractory Greater Trochanteric Pain Syndrome (GTPS) vs control. The investigator team hypothesizes that the new TENEX can improve the pain level for individuals with GTPS to help those individuals perform their activities of daily living (ADLs), e.g., walking, standing, and side-lying, as well as demonstrate less medication utilization. The study predicts that this percutaneous outpatient procedure can decrease pain, increase mobility, and decrease medication utilization. The study team hypothesizes that PUT can improve the pain level and function for individuals suffering with GTPS. The study will assess walking, standing, and side-lying tolerance, as well as medication utilization. The investigator team predicts that this percutaneous outpatient procedure can decrease pain and medication utilization while increasing mobility.
Sponsor: Montefiore Medical Center
Yes, this clinical trial (NCT05710627) has an active research site in The Bronx, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for greater trochanteric pain syndrome treatment options in The Bronx, NY, this clinical trial (NCT05710627) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our The Bronx research site is actively enrolling participants for this clinical trial. You'll receive care from experienced greater trochanteric pain syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all greater trochanteric pain syndrome clinical trials near you to find additional studies recruiting in your area.
See all chronic pain clinical trials recruiting in The Bronx — not just this study.
Browse Chronic Pain Trials in The Bronx →